127 related articles for article (PubMed ID: 26209408)
1. Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients.
Le Guillou-Guillemette H; Ducancelle A; Bertrais S; Lemaire C; Pivert A; Veillon P; Bouthry E; Alain S; Thibault V; Abravanel F; Rosenberg AR; Henquell C; André-Garnier E; Petsaris O; Vallet S; Bour JB; Baazia Y; Trimoulet P; André P; Gaudy-Graffin C; Bettinger D; Larrat S; Signori-Schmuck A; Saoudin H; Pozzetto B; Lagathu G; Minjolle-Cha S; Stoll-Keller F; Pawlotsky JM; Izopet J; Payan C; Lunel-Fabiani F
J Clin Virol; 2015 Aug; 69():203-9. PubMed ID: 26209408
[TBL] [Abstract][Full Text] [Related]
2. Duplication of the V3 domain in hepatitis C virus (1b) NS5A protein: Clonal analysis and physicochemical properties related to hepatocellular carcinoma occurrence.
Petsaris O; Vallet S; Le Guillou-Guillemette H; Veillon P; Gouriou S; Barbier G; Nousbaum JB; Saliou P; NKontchou G; Trinchet JC; Lunel-Fabiani F; Payan C
J Clin Virol; 2016 Jan; 74():19-25. PubMed ID: 26655076
[TBL] [Abstract][Full Text] [Related]
3. Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma.
Le Guillou-Guillemette H; Pivert A; Bouthry E; Henquell C; Petsaris O; Ducancelle A; Veillon P; Vallet S; Alain S; Thibault V; Abravanel F; Rosenberg AA; André-Garnier E; Bour JB; Baazia Y; Trimoulet P; André P; Gaudy-Graffin C; Bettinger D; Larrat S; Signori-Schmuck A; Saoudin H; Pozzetto B; Lagathu G; Minjolle-Cha S; Stoll-Keller F; Pawlotsky JM; Izopet J; Payan C; Lunel-Fabiani F; Lemaire C
PLoS One; 2017; 12(4):e0174651. PubMed ID: 28394908
[TBL] [Abstract][Full Text] [Related]
4. Evolution of hepatitis C virus non-structural 5A gene in the progression of liver disease to hepatocellular carcinoma.
De Mitri MS; Cassini R; Bagaglio S; Morsica G; Andreone P; Marino N; Bernardi M
Liver Int; 2007 Oct; 27(8):1126-33. PubMed ID: 17845542
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of wild-type in NS5A-PKR protein kinase binding domain in HCV-related hepatocellular carcinoma.
De Mitri MS; Morsica G; Cassini R; Bagaglio S; Zoli M; Alberti A; Bernardi M
J Hepatol; 2002 Jan; 36(1):116-22. PubMed ID: 11804673
[TBL] [Abstract][Full Text] [Related]
6. Association of amino acid variations in the NS5A and E2-PePHD region of hepatitis C virus 1b with hepatocellular carcinoma.
Hung CH; Chen CH; Lee CM; Wu CM; Hu TH; Wang JH; Yen YH; Lu SN
J Viral Hepat; 2008 Jan; 15(1):58-65. PubMed ID: 18088246
[TBL] [Abstract][Full Text] [Related]
7. High amino acid variability within the NS5A of hepatitis C virus (HCV) is associated with hepatocellular carcinoma in patients with HCV-1b-related cirrhosis.
Giménez-Barcons M; Franco S; Suárez Y; Forns X; Ampurdanès S; Puig-Basagoiti F; Sánchez-Fueyo A; Barrera JM; Llovet JM; Bruix J; Sánchez-Tapias JM; Rodés J; Saiz JC
Hepatology; 2001 Jul; 34(1):158-67. PubMed ID: 11431747
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.
Nousbaum JB; Pol S; Nalpas B; Landais P; Berthelot P; Bréchot C
Ann Intern Med; 1995 Feb; 122(3):161-8. PubMed ID: 7810932
[TBL] [Abstract][Full Text] [Related]
9. Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b.
Alkhatib M; Di Maio VC; De Murtas V; Polilli E; Milana M; Teti E; Fiorentino G; Calvaruso V; Barbaliscia S; Bertoli A; Scutari R; Carioti L; Cento V; Santoro MM; Orro A; Maida I; Lenci I; Sarmati L; Craxì A; Pasquazzi C; Parruti G; Babudieri S; Milanesi L; Andreoni M; Angelico M; Perno CF; Ceccherini-Silberstein F; Svicher V; Salpini R; On Behalf Of Hirma Hepatocarcinoma Innovative Research MArkers And Fondazione Vironet C Hcv Virology Italian Resistance
Viruses; 2021 Apr; 13(5):. PubMed ID: 33922732
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms of the core, NS3, and NS5A proteins of hepatitis C virus genotype 1b associate with development of hepatocellular carcinoma.
El-Shamy A; Shindo M; Shoji I; Deng L; Okuno T; Hotta H
Hepatology; 2013 Aug; 58(2):555-63. PubMed ID: 23281009
[TBL] [Abstract][Full Text] [Related]
11. Characterization and evolution of NS5A quasispecies of hepatitis C virus genotype 1b in patients with different stages of liver disease.
Franco S; Giménez-Barcons M; Puig-Basagoiti F; Furcic I; Sánchez-Tapias JM; Rodés J; Sáiz JC
J Med Virol; 2003 Oct; 71(2):195-204. PubMed ID: 12938193
[TBL] [Abstract][Full Text] [Related]
12. Complex Association of Virus- and Host-Related Factors with Hepatocellular Carcinoma Rate following Hepatitis C Virus Clearance.
Akuta N; Suzuki F; Sezaki H; Kobayashi M; Fujiyama S; Kawamura Y; Hosaka T; Kobayashi M; Saitoh S; Suzuki Y; Arase Y; Ikeda K; Kumada H
J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30381417
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Hepatitis C Virus NS5A Region in Patients with Cirrhosis Using an Ultra-Deep Pyrosequencing Method.
Keskin F; Ciftci S; Akyuz F; Abaci N; Cakiris A; Akyuz U; Demir K; Besisik F; Ustek D; Kaymakoglu S
Clin Lab; 2017 Sep; 63(9):1439-1445. PubMed ID: 28879707
[TBL] [Abstract][Full Text] [Related]
14. Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy.
Veillon P; Payan C; Le Guillou-Guillemette H; Gaudy C; Lunel F
World J Gastroenterol; 2007 Feb; 13(8):1195-203. PubMed ID: 17451199
[TBL] [Abstract][Full Text] [Related]
15. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.
Bellentani S; Pozzato G; Saccoccio G; Crovatto M; Crocè LS; Mazzoran L; Masutti F; Cristianini G; Tiribelli C
Gut; 1999 Jun; 44(6):874-80. PubMed ID: 10323892
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus genotypes and the development of hepatocellular carcinoma.
Stankovic-Djordjevic D; Djordjevic N; Tasic G; Dinic M; Karanikolic A; Pesic M
J Dig Dis; 2007 Feb; 8(1):42-7. PubMed ID: 17261134
[TBL] [Abstract][Full Text] [Related]
17. Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapy.
Kumthip K; Pantip C; Chusri P; Thongsawat S; O'Brien A; Nelson KE; Maneekarn N
J Viral Hepat; 2011 Apr; 18(4):e117-25. PubMed ID: 20955493
[TBL] [Abstract][Full Text] [Related]
18. NS5A(ISDR-V3) region genetic variability of Tunisian HCV-1b strains: Correlation with the response to the combined interferon/ribavirin therapy.
Bouzgarrou N; Hassen E; Mahfoudh W; Gabbouj S; Schvoerer E; Ben Yahia A; Ben Mami N; Triki H; Chouchane L
J Med Virol; 2009 Dec; 81(12):2021-8. PubMed ID: 19856481
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus 1b(II) infection and development of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma: a case-control study in Japan.
Tanaka H; Tsukuma H; Yamano H; Okubo Y; Inoue A; Kasahara A; Hayashi N
J Epidemiol; 1998 Oct; 8(4):244-9. PubMed ID: 9816816
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus (HCV) genotype 1 NS5A resistance-associated variants are associated with advanced liver fibrosis independently of HCV-transmission clusters.
Parczewski M; Kordek J; Janczewska E; Pisula A; Łojewski W; Socha Ł; Wawrzynowicz-Syczewska M; Bociąga-Jasik M; Szymczak A; Cielniak I; Siwak E; Mularska E; Aksak-Wąs B; Urbańska A; Lübke N
Clin Microbiol Infect; 2019 Apr; 25(4):513.e1-513.e6. PubMed ID: 29981869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
